Press Release | Bentham Science journals improve impact factor ratings in 2019


The latest edition of Journal Citation Reports® 2019 has been published recently, and according to the report, Bentham Science Publishers (BSP) journals have significantly improved their Impact Factors. Current Neuropharmacology is leading the list again with the highest impact factor (IF: 4.568) among all the journals. In total, 40 BSP journals have received Impact Factor ratings this year. The latest results in the JCR 2019 reflect the high quality of research published by Bentham Science.

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here:


Read full press release to find out more at:

AIMS & SCOPE – Current Stem Cell Research & Therapy

Aims & Scope

Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research




For more details, please visit:

MOST ACCESSED ARTICLE – Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis

Journal Name: Current Stem Cell Research & Therapy

Author(s): Yue Li, Daxiang Jin*, Weixing Xie, Longfei Wen, Weijian Chen, Jixi Xu, Jinyong Ding, Dongcheng Ren, Zenglin Xiao.





Osteoporosis is a common age-related disorder characterized by low bone mass and deterioration in bone microarchitecture, leading to increased skeletal fragility and fracture risk. The pathophysiology of osteoporosis is multifactorial. It is related to the imbalance between osteoblasts and osteoclasts; reduced bone mass and increased adipogenesis in the bone marrow. Moreover, angiogenesis, inflammatory process and miRNAs have shown effects in the formation of osteoporosis. In the recent years, mesenchymal stem cells (MSCs) have been regarded as an excellent choice for cell-based tissue engineering therapy of osteoporosis. Growing evidence showed that paracrine effect has been considered as the predominant mechanism for the role of MSCs in tissue repair. Recently, many studies have proposed that MSCs-derived exosomes are effective for a variety of diseases like cancer, cardiovascular diseases, etc. However, whether the MSCs-derived exosomes could serve as a novel therapeutic tool for osteoporosis has not clearly described. In this review, we summarize the MSCs-derived exosomes and the relationship with osteogenesis, osteoclast differentiation, angiogenesis, immune processes and miRNAs. Finally, we suggest that MSCs-derived exosomes might be a promising therapeutic method for osteoporosis in the future.


For more details, please visit:

OPEN ACCESS ARTICLE – Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine

Journal Name: Current Stem Cell Research & Therapy

Author(s): Sheng Yi, Fei Ding, Leiiei Gong, Xiaosong Gu.





The extracellular matrix is produced by the resident cells in tissues and organs, and secreted into the surrounding medium to provide biophysical and biochemical support to the surrounding cells due to its content of diverse bioactive molecules. Recently, the extracellular matrix has been used as a promising approach for tissue engineering. Emerging studies demonstrate that extracellular matrix scaffolds are able to create a favorable regenerative microenvironment, promote tissue-specific remodeling, and act as an inductive template for the repair and functional reconstruction of skin, bone, nerve, heart, lung, liver, kidney, small intestine, and other organs. In the current review, we will provide a critical overview of the structure and function of various types of extracellular matrix, the construction of three-dimensional extracellular matrix scaffolds, and their tissue engineering applications, with a focus on translation of these novel tissue engineered products to the clinic. We will also present an outlook on future perspectives of the extracellular matrix in tissue engineering and regenerative medicine.



For more details, please visit:

EDITOR’S CHOICE – Deciphering the Role of microRNAs in Regulation of Immune Surveillance, Self-Tolerance and Allograft Transplant Outcome

Journal: Current Stem Cell Research & Therapy

Author(s): Cherry S. Leung, Song Lu, Jiatao Li, William KK Wu, Kathy O. Lui


MicroRNAs are small non-coding RNAs that can modulate gene expression at posttranscriptional level, and they participate in almost all important biological processes. Immune system is elaborately regulated to maintain the equilibrium between immunity and tolerance. Recent studies have revealed significant functions of microRNAs in the maintenance of immune homeostasis using both cell and transgenic mouse models. In collaboration with various transcriptional factors and cytokines, microRNAs constitute an effective and flexible regulatory network governing the development and activation of immune cells; as well as maintenance of immune tolerance. In this review, microRNAs involved in T cell development, proliferation, and lineage differentiation will be summarized. Based on current knowledge, the function of microRNAs in establishing and maintaining immune tolerance will also be discussed in relation to determining the outcome of allograft transplantation.

Read more here:



Current Pharmacogenomics and Personalized Medicine 15-2

Current Medicinal Chemistry 25-6

Current Alzheimer Research 15-4

Current Topics in Medicinal Chemistry 17-32

Current Stem Cell Research & Therapy 13-3 



Current Stem Cell Research & Therapy 13, Issue 2

Current Metabolomics 6, Issue 1

Current Proteomics 15, Issue 1

Current Medicinal Chemistry 25, Issue 1

Current Medicinal Chemistry 25, Issue 2





Recent Patents on Inflammation & Allergy Drug Discovery 11-2

Current Rheumatology Reviews 13-3

Current Bioinformatics 12-6

Current Drug Metabolism 18-9

Current Stem Cell Research & Therapy 13-1

Current Organic Chemistry 21-25

Current Smart Materials 2-2



Recent Patents on Mechanical Engineering 10-3

Letters in Drug Design & Discovery 14-12

Current Topics in Medicinal Chemistry 17-27

Recent Innovations in Chemical Engineering 10-1

Current Stem Cell Research & Therapy 12-8

Current Organic Chemistry 21-21

Current Pharmaceutical Design 23-28

Letters in Organic Chemistry 14-10


%d bloggers like this: